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Rational truncation of aptamer for 
cross-species application to detect 
krait envenomation
Abhijeet Dhiman1,6, Anjali Anand2, Anita Malhotra  3, Eshan Khan4, Vishal Santra5, 
Amit Kumar4 & Tarun Kumar Sharma2
In majority of snakebite cases, the snake responsible for the bite remains unidentified. The traditional 
snakebite diagnostics method relies upon clinical symptoms and blood coagulation assays that do not 
provide accurate diagnosis which is important for epidemiological as well as diagnostics point of view. 
On the other hand, high batch-to-batch variations in antibody performance limit its application for 
diagnostic assays. In recent years, nucleic acid aptamers have emerged as a strong chemical rival of 
antibodies due to several obvious advantages, including but not limited to in vitro generation, synthetic 
nature, ease of functionalization, high stability and adaptability to various diagnostic formats. In the 
current study, we have rationally truncated an aptamer developed for α-Toxin of Bungarus multicinctus 
and demonstrated its utility for the detection of venom of Bungarus caeruleus. The truncated aptamer 
α-Tox-T2 (26mer) is found to have greater affinity than its 40-mer parent counterpart α-Tox-FL. The 
truncated aptamers are characterized and compared with parent aptamer for their binding, selectivity, 
affinity, alteration in secondary structure and limit of detection. Altogether, our findings establish the 
cross-species application of a DNA aptamer generated for α-Toxin of Bungarus multicinctus (a snake 
found in Taiwan and China) for the reliable detection of venom of Bungarus caeruleus (a snake found in 
the Indian subcontinent).
Snakebite is one of the major neglected public health problems that primarily affect rural populations in tropical 
and sub-tropical countries globally1–7. About 5.4 million snakebites occur each year, resulting in 1.8 to 2.7 million 
cases of envenomation with 81,410 to 137,880 deaths and ~400,000 amputations and other permanent disabilities 
each year2. In India alone ~45,900 deaths are recorded annually due to snakebites3,4. However, these figures may 
not be the actual representation as a large number of snakebite envenomation remain unreported1. Treatment of 
snakebite primarily relies upon administration of anti-venom (AV). These AVs are usually obtained from the sera 
of equines, which have been hyperimmunized with a cocktail of one or more snake venoms and an adjuvant to 
boost the immune system7. Commercial AV producers usually purify the immunoglobulin or F(ab)2 fragment 
from the serum, and in order to improve the stability, it can be lyophilized and transported in the form of dry 
powder that is reconstituted at the time of use7. In absence of an accurate diagnostic test for snakebite, often a 
large quantity of poly-specific AV is administered in the victim that may increases the risk of various adverse 
reactions such as urticaria, serum sickness, and life-threatening anaphylaxis due to its poly-specific nature and 
equine origin6–10. In order to avoid such AV-associated complexities, accurate diagnosis of snakebite is very crit-
ical6 that will allow the administration of a monospecific AV that is reported to have fewer cases of adverse 
reactions (only 12.9% cases vs 79% cases in poly-specific AV treated subjects)11,12. Current diagnostic approaches 
are centred around manifestations of snakebite associated various symptoms and a blood coagulation test6. In 
recent years, antibody-based immunoassays have gained significant attention in snakebite diagnosis but it suffers 
from an inherent disadvantage including high-batch-to-batch variation that limit its application in real diagnostic 
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situations6,13,14. A further challenge associated with snakebite diagnosis is the variable nature of snake venom, 
which is a highly complex mixture of proteins, enzymes, carbohydrates, peptides and other substances1,7,15 that 
poses a great challenge for the development of a polyclonal antibody-based specific diagnostic tool. Development 
of a monoclonal antibody that specifically recognizes a particular venom component is challenging and more-
over, maintenance of such clones requires extensive cell culture facilities along with cold storage6,7,15. However, 
the diagnostic challenge posed by venom variability can be addressed by designing a diagnostic reagent with an 
ability to recognize an epitope shared by venom of geographically distinct population of a snake species.
In recent years, a new class of nucleic acids called ‘aptamers’ have spurred great interest in the scientific 
community and diagnostic industry owing to their ability to replace antibodies in all possible diagnostic for-
mats13,16–21. Aptamers are structured nucleic acids that can be generated through a process of in vitro evolution 
called Systematic Evolution of Ligands by EXponential enrichment (SELEX)14,19,22,23. Aptamers are strong chem-
ical rivals of antibodies and are also known as aptabodies or chemical antibodies22. They evince several obvious 
advantages over their antibody counterparts including, but not limited to, high stability, room temperature stor-
age, ease of synthesis and functionalization, ethical advantages as the need for animal subjects is obviated, and 
negligible batch-to-batch variation. In recent years, aptamer technology has attained an impressive growth in the 
area of diagnosis, and a large number of aptamers have been reported against various analytes ranging from metal 
ions, small molecules, protein, toxins and even whole bacterial and cancer cells14,19,23,24. More recently, the utility 
of aptamers has also been demonstrated for the detection of α- bungarotoxin24, a major-constituent (~60%) of 
the venom of Bungarus multicinctus (many-branded krait)7,24. Bungarus multicinctus is a highly venomous snake 
distributed throughout the South-east Asia and East Asian islands. One of the major constituents of the venom, 
α-Bungarotoxin, binds irreversibly and competitively to the acetylcholine receptor of the neuromuscular junction 
and induces paralysis, respiratory failure and eventually causes the death of the victim7. The Indian counterparts 
of B. multicinctus are B. caeruleus, B. niger, B. walli, B. sindanus, and B. fasciatus. However, B. caeruleus is the 
most common one and it is an important member of ‘BigFour’ group that cause the majority of envenomation 
in the Indian subcontinent25,26. A BLAST search reveals that the α-bungarotoxin from B. caeruleus is ~80% sim-
ilar to the α-bungarotoxin from B. multicinctus (Table 1). Based on this information, we hypothesized that an 
aptamer generated against α-bungarotoxin of B. multicinctus should obviate the need for aptamer generation 
against α-bungarotoxin of B. caeruleus (krait) for the diagnosis of krait bite27. With this aim, we evaluated the 
previously reported aptamer (α-Tox-FL) for its ability to detect the venom of B. caeruleus. In addition, we showed 
that the rationally truncated aptamer displayed high affinity and specificity comparable to the parent aptamer. 
The truncated variant developed in this study may provide a tool for the epidemiological studies and diagnosis of 
krait bite in Indian context. The study could be a significant contribution to a multi-pronged program to reduce 
mortality from snakebite in India.
Toxin Uniprot/NCBI ID FASTA Sequence
Sequence similarity with 
B. caeruleus
α-Toxin Bungarotoxin  
B. multicinctus Uniprot P60615 (3L21A_BUNMU)
>sp|P60615|3L21A_BUNMU Alpha-bungarotoxin isoform A31
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Table 1. NCBI BLAST results showing sequence similarity between α-Toxin of B. multicinctus and α-Toxin of 
B. caeruleus, B. fasiatus and B. niger.
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Materials and Methods
Reagents and Chemicals. All routine reagents were procured from Sigma Aldrich, USA, unless otherwise 
mentioned. Oligonucleotides used in the study were procured from Integrated DNA Technologies (IDT, USA). 96 
well plates (MaxiSorpTM) were procured from Nunc, USA. Bovine Serum Albumin (BSA) and 4-(2-hydroxyeth-
yl)-1-piperazineethanesulfonic acid (HEPES) was procured from Sigma Aldrich, USA. 3, 3′, 5, 5′-tetramethylb-
enzidine (TMB) (BD OptEIA™) was procured from BD Biosciences, USA. Snake venom was obtained from 
wild specimens collected under permit numbers 5141/WL/4R-6/2017, A.33011/5/2011-CWLW/305, and WL/
Research Study/WLM/2341 issued by West Bengal, Mizoram and Himachal Pradesh Forest Departments, India, 
which were released after milking and whose specific identity was confirmed by expert herpetologists. Snakes 
were handled according to relevant guidelines or regulations. Ethical permission to obtain snake venom from 
wild snake was taken from the Institutional Ethics Committee, Bangor University UK and the Calcutta National 
Medical College, India. In addition to this, snake venom was also procured from K.V. Institute Uttar Pradesh, 
India. Premium Serums and Vaccines Pvt. Ltd. Pune, Maharashtra, India has also provided venom of ‘Big Four’ 
species as a generous gift. Permission to handle the snake venom at THSTI was taken from the Institutional 
Biosafety Committee, THSTI, Faridabad-121001, Haryana, India.
Protein BLAST Search. In order to assess the sequence similarity between α-bungarotoxin of B. multicinc-
tus and B. caeruleus protein sequence of α-bungarotoxin from both the aforementioned species was subjected 
to NCBI protein BLAST search (https://blast.ncbi.nlm.nih.gov). Protein sequence of α-bungarotoxin of B. mul-
ticinctus was used as a query while Protein sequence of α-bungarotoxin of B. caeruleus was used as a subject 
(Table 1).
Truncation of Aptamer. α-bungarotoxin specific 40-mer aptamer (α-Tox-FL) was submitted to M-fold 
webserver (http://unafold.rna.albany.edu/?q=mfold/DNA-Folding-Form) to predict its secondary structure28. 
Two variants of α-Tox-FL (40-mer) were designed as guided by its secondary structure. These two variants were 
designated as α-Tox-T1 (14-mer) and α-Tox-T2 (26-mer) which is further assessed for their ability to bind 
venom of B. caeruleus in comparison to its parent aptamer α-Tox-FL.
Enzyme Linked Aptamer Assay (ELAA). Binding of α-Tox-FL, α-Tox-T1 and α-Tox-T2 were evaluated 
using ELAA as described by Ye et al.7. Briefly, a 96-wellplate was coated with 1 µg/well venom of B. caeruleus in 
100 µL (0.1 mol/L) sodium bicarbonate buffer pH 9.6, followed by two washes with 200 µL wash buffer (20 mM 
HEPES pH 7.4, supplemented with 150 mM NaCl, 5 mM KCl, 2 mM MgCl2 and 2 mM CaCl2) containing 0.05% 
Tween 20. Wells were then blocked with 100 µL of 1 mg/mL BSA solution in binding buffer (was buffer without 
Tween-20) for 2 hr at room temperature (RT). After blocking, the wells were washed twice with wash buffer to 
remove unbound protein. The biotinylated aptamers (50 pmol) were heated at 92 °C for 10 min, cooled on ice and 
brought to RT. Fifty picomole (per well) of 5′ biotinylated aptamer was then added to the individual wells followed 
by 40 minutes incubation at RT. Subsequently, the wells were washed 3 times with wash buffer. Following this, 
100 µL of 1:1000 dilution of streptavidin-HRP conjugate in binding buffer was added per well for 40 minutes at 
RT. The wells were washed as previously described. TMB (100 µL) was added as a substrate to each well, incu-
bated for 5 min and the reaction was quenched by adding 100 µL of 5% H2SO4 to each well. The venom-bound 
aptamer-streptavidin complex was quantified at 450 nm (O.D.450) using M2e plate reader (Molecular Devices 
USA). In this experiment, a buffer-coated well was served as an antigen control and data was plotted as ΔO.D. 
450 nm (O.D.450 nm of test - O.D.450 nm of antigen control).
Cross-reactivity testing. The selected aptamer candidates were tested in ELAA format against 8 different 
snake venoms including B. caeruleus, namely venom obtained from Nana naja, N. kaouthia, N. oxiana, Daboia 
russelii, B. caeruleus, B. fascinatus, B. niger, and Echis carinatus. These species were chosen based on their distri-
bution and importance in terms of snakebite in the Indian subcontinent. In order to examine the cross reactivity 
of parent and truncated aptamer candidates, 1 µg/well of each venom was coated on to a 96-well plate in 100 µL 
of coating buffer and kept at 4 °C overnight. The rest of the ELAA procedure was performed as described in the 
ELAA section above. A heat map was created as a function of absorbance of each aptamer candidate for tested 
venoms.
Circular Dichroism. The Circular Dichroism (CD) experiment was performed on a J-815 Spectropolarimeter 
(JASCO, Tokyo Japan) to evaluate the secondary structure of full length and truncated aptamer candidates. 
A quartz cuvette with 0.2 cm path length was used to record the spectra of samples containing 20 μM of each 
aptamer (α-Tox-FL, α-Tox-T1 and α-Tox-T2) in binding buffer.
Determination of apparent dissociation constant (Kd) of aptamer candidates. To determine the 
Kd of parent and the truncated aptamer candidate against venom of B. caeruleus, 1 µg venom of B. caeruleus/well 
was coated at 4 °C overnight on a 96 well plate in 100 µL of coating buffer. After blocking with 100 µL of 1 mg/mL 
BSA solution prepared in binding buffer, a range of aptamer concentrations (2–500 nM) was added. ELAA was 
performed as described above. O.D.450 was plotted as a function of aptamer concentration and Kd was determined 
by the below mentioned non-linear regression for one-site binding using Graph-pad Prism version 5.02. Y repre-
sents the aptamer binding, X is aptamer concentration and Bmax is maximum binding.
= × +Y Bmax X Kd X/( )
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Limit of detection of parent and truncated aptamer. The limit of detection (LOD) of venom of B. 
caeruleus for parent and truncated variant was determined by ELAA. In each case, a range of B. caeruleus venom 
was taken (2–1000 ng/well). Rest of the procedure remain the same as followed for ELAA.
Evaluation of aptamer binding for geographically distinct venoms. In order to demonstrate the 
application of aptamer for species identification, we have evaluated the aptamer binding against venom using 
ELAA as described above. For this, the geographically distinct population of Bungarus caeruleus and other species 
from two different states of India (Uttar Pradesh and Maharashtra) was used in this assay.
Results and Discussion
The present work establishes the role of truncation in designing shorter yet effective aptamer for the detection 
of venom of B. caeruleus. This was achieved through sequential approaches starting with the BLAST search 
of α-bungarotoxin of B. multicinctus and B. caeruleus, followed by secondary-structure guided truncation of 
α-Tox-FL.
Protein BLAST Search. Protein BLAST Search of the protein sequence of α-bungarotoxin of B. multicinc-
tus and B. caeruleus revealed that these toxins share ~87% identity with 80% query coverage (Table 1) despite 
the species-level differences. However, it shows poor sequence similarity with B. fasciatus and B. niger. Based on 
this observation, we hypothesized that the aptamer generated for α-bungarotoxin of B. multicinctus should have 
high probability of binding to venom of B. caeruleus that also contains α-bungarotoxin, with minor differences in 
comparison to α-bungarotoxin of B. multicinctus.
Truncation of B. multicinctus α-Toxin specific aptamer. As it is well known fact that only a portion 
of aptamer is critical for its function and target binding and truncation of aptamer may leads to improvement 
in aptamer binding14,16,29. Thus, as a first step to establish the structure-activity relationship α-Tox-FL (40-mer 
DNA aptamer) developed for α-Toxin of B. multicinctus, it was first subjected to Mfold analysis using DNA 
parameters28. Mfold predicted a secondary structure of α-Tox-FL with a minimum free energy of −4.06 kcal/
mol. This secondary structure predicted by Mfold (Fig. 1A) evinced that the α-Tox-FL contain two stem-loop-like 
structures. Therefore, to establish their independent role we have truncated the parent aptamer into two sec-
ondary structures guided truncated variant (α-Tox-T1 and α-Tox-T2). The first variant (α-Tox-T1) is a 14-mer 
stem-loop-like structure having three Watson-Crick base-pairs (AT and two GC repeats) in the stem while the 
loop is formed by 5′ GGTGT 3′ sequence. The secondary structure of α-Tox-T2 is relatively complex and it 
contains two stems. Stem-1 contain three Watson-Crick base-pairs (AT and two GC repeats, similar to the stem 
of α-Tox-T1) while Stem-2 contains three Watson-Crick base-pairs (3GC repeats) and a non-Watson-Crick 
base-pair (GA). Loop-1 that connects Stem-1 and Stem-2 is formed by a 5′ AGGCA 3′ sequence while Loop-2 
associates with Stem-2 of α-Tox-T2 and formed by 5′ GACAT 3′. To evaluate the effect of truncation on bind-
ing to α-bungarotoxin of B. caeruleus, all three 5′ biotinylated aptamer (α-Tox-FL, α-Tox-T1 and α-Tox-T2) 
was assessed through ELAA. ELAA data clearly demonstrated that all three aptamer candidates can bind to the 
venom of B. caeruleus (Fig. 1B). However, it is evident that binding of α-Tox-T2 is comparable to the binding of 
the parent aptamer α-Tox-FL, while α-Tox-T1 play only minor role in binding (Fig. 1B). This result unequivo-
cally demonstrates the power of post-SELEX optimization and rational engineering of an aptamer to identify the 
smallest functional unit within the aptamer. These findings are in agreement with the previous reports suggesting 
that the truncated aptamer can perform comparable or sometimes superior to the parent aptamer candidate14,29,30.
Figure 1. (A) Secondary structure of α-Tox-FL, α-Tox-T1 and α-Tox-T2 aptamers as obtained by Mfold. Red 
dotted line represents point of truncation. (B) Showing a comparison of binding of α-Tox-FL, α-Tox-T1 and 
α-Tox-T2 aptamers to B. caeruleus venom by ELAA.
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Cross-reactivity testing. The parent aptamer (α-Tox-FL) was identified for α-bungarotoxin of B. mul-
ticinctus by Veedu’s group24 but the potential of this aptamer to detect this toxin in crude venom or its specificity, 
was not established. Here, the ELAA data (Fig. 2A) unequivocally demonstrated that all three aptamers have 
very high selectivity for venom of B. caeruleus in comparison to the venom of other seven species tested. The 
binding of individual aptamer candidates to the tested venom is shown in the form of a three-colour gradient 
heat-map (red coloured box depicts the highest binding while blue represent the lowest binding) (Fig. 2B). Taken 
together, binding and selectivity of α-Tox-T2 is comparable to its parent counterpart. Although α-Tox-T1 retains 
high selectivity, its binding is poor in comparison to α-Tox-FL and α-Tox-T2. Interestingly, despite the fact that 
when α-Tox-FL was identified, no crude venom was used to rule out the cross-reactivity24 of the aptamer pool 
against venom of the species used in the current study but none of the aptamer has shown cross-reactivity with 
the venom of other species. Conclusively, aptamer designed for α-Toxin of B. multicinctus has been shown to effi-
ciently detect α-Toxin of B. caeruleus in crude venom, owing to the primary sequence similarity (~80%) between 
α-Toxins derived from these two species (Table 1). However, it was unable to detect α-Toxin from other Bungarus 
sps (B. fasciatus and B. niger). A plausible explanation could be that α-Toxins of B. fasciatus and B. niger has lower 
sequence similarity (26% and 6% respectively).
Circular Dichroism (CD). Next, the change in the structure of the aptamers, if any, as a result of truncation 
was studied using CD. The CD spectrum of α-Tox-FL displayed a negative peak at 246 nm and two positive 
peaks at 218 nm and 272 nm, signifying a stem loop type B-DNA structure14,31 (Fig. 3A). Similarly, α-Tox-T1 and 
α-Tox-T2 showed negative peak at 246 nm and two positive peaks at 218 nm and 272 nm confirming the forma-
tion of a stem loop type B-DNA structure similar to the parent (Fig. 3B,C). It is evident from the CD data that the 
secondary structure of the truncated aptamers remains unaltered.
Apparent dissociation constant (Kd) of aptamer candidates. The apparent dissociation constants (Kd) 
of α-Tox-FL, α-Tox-T1 and α-Tox-T2 aptamers were determined by non-linear regression method for one-site 
binding (Graph-pad Prism version 5.02). The aptamers were ranked in terms of Kd (highest to lowest affinity) as 
α-Tox-T2 (2.85 nM) > α-Tox-FL (18.01 nM) > α-Tox-T1 (44.83 nM, Fig. 4). α-Tox-T2 has ~6.3 fold higher affinity 
than its parent aptamer, suggesting that truncation leads to improved affinity in case of α-Tox-T2. On the other hand, 
α-Tox-T1 display poor affinity suggesting that alone it does not have any significant role in binding. These results 
are in agreement with the previous reports demonstrating that truncation leads to an improvement in affinity14,29,30.
Figure 2. (A) Showing ELAA results representing selectivity of α-Tox-FL, α-Tox-T1 and α-Tox-T2 aptamers 
to B. caeruleus venom. (B) Selectivity of α-Tox-FL, α-Tox-T1 and α-Tox-T2 aptamers to B. caeruleus venom 
is represented as three-colour gradient heat map (a heat-map representation of ELAA response). Red colour 
indicates highest binding while blue represent the lowest binding.
Figure 3. Circular dichroism (CD) spectrum of α-Tox-FL (A), α-Tox-T1 (B) and α-Tox-T2 (C) aptamers. CD 
spectra indicate typical B-type stem-loop structure of aptamer that remain unaltered even after truncation.
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Limit of detection of parent and truncated aptamer. The truncated aptamer α-Tox-T2 could detect 
B. caeruleus venom in as low quantities as 2 ng crude venom, while the parent aptamer α-Tox-FL has a lower 
detection limit of 8 ng venom under a similar set of conditions (Fig. 5). This finding clearly demonstrates that, in 
terms of lower-end detection limit, α-Tox-T2 is superior to its parent aptamer. The possible reason for the supe-
rior detection by the truncated aptamer is due to its improved affinity over parent aptamer.
Figure 4. Apparent dissociation constant curve derived through non-linear regression representing binding 
affinity (Kd) of α-Tox-FL (A), α-Tox-T1 (B) and α-Tox-T2 (C) aptamers.
Figure 5. Low end detection limit of α-Tox-FL and α-Tox-T2 aptamers. α-Tox-T2 represents more sensitive 
detection of B. caeruleus venom in comparison to its parent counterpart.
Figure 6. Binding of aptamer to geographically distinct venom of B. caeruleus and other members of ‘BIG 
Four’ group. KV in parentheses represents venom procured from KV Institute Uttar Pradesh India while P in 
parentheses represent venom obtained from Premium Serums and Vaccines Pvt.Ltd. Pune, Maharashtra, India.
www.nature.com/scientificreports/
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Evaluation of aptamer binding for geographically distinct venoms. To demonstrate the application 
of aptamer for species identification, in addition to the snake venom obtained from West Bengal (eastern part of 
India, Figs 1 and 2) we have also evaluated the aptamer binding against venom obtained from geographically dis-
tinct populations of Bungarus caeruleus and other species from two other states, Uttar Pradesh and Maharashtra 
(northern and western regions of India respectively). ELAA results (Fig. 6) clearly demonstrated that both the 
parent and truncated aptamer selectively binds to the venom of Bungarus caeruleus regardless of geographical 
origin. This result clearly indicates that aptamer is possibly binding to an aptatope which is common in the ven-
oms of Bungarus caeruleus used in the current study.
Conclusion
As snake venom is a highly complex mixture of various biological molecules ranging from carbohydrates, protein, 
enzymes, lipids and other substances, specific detection of snake venom is highly challenging and often cannot be 
achieved by using antibodies, as they show high cross-reactivity. Thus, to address this challenge as a proof-of-concept 
study, we have shown here that rational truncation is an efficient strategy to develop shorter yet efficient binders from 
the parent aptamer without compromising its affinity, selectivity and secondary structure. Importantly, we have 
demonstrated that if the aptamer and target selection is made intelligently then the aptamer can have cross-species 
application as shown in the current study, in which an aptamer designed for α-Toxin of B. multicinctus has been 
shown to efficiently detect α-Toxin of B. caeruleus in crude venom. Being a synthetic reagent, aptamers obviate the 
need for the resource-intensive facilities required for antibody production. Further, there is enormous potential in 
the diagnostic application of aptamers for the other components present in venom of other snake species. To take 
this proof of concept to the next level of evaluation, a decent number of krait bites and control samples derived from 
geographically distinct patients of different age groups is required in future. Such evaluation will certainly pave the 
way for translation of the aptamer-based diagnostic test for point-of-care diagnosis of Indian krait bite.
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